Lifnua Tablets 45mg, manufactured by MSD, contain Gafapixant citrate, a P2X3 receptor antagonist developed for the treatment of chronic cough. The standard for this medication is 45mg per tablet with YJ code 2290001F1028.
Lifnua Tablets 45mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →